Back to Search
THADDEUS PAJAK, DO
DO
Family Medicine Physician
NPI: 1952744054IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OS019106(PA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2011
Research & Publications (20)
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
PMID 19667273·J Clin Oncol·2009
4-observational
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
PMID 19246242·Lancet Oncol·2009
1-meta
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.
PMID 19671739·Mol Cancer Ther·2009
3-trial
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
PMID 17889449·Int J Radiat Oncol Biol Phys·2008
3-trial
Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial.
PMID 17762442·Am J Clin Oncol·2007
8-other
Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study.
PMID 17955501·Cancer·2007
3-trial
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
PMID 17716826·Int J Radiat Oncol Biol Phys·2007
2-rct
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
PMID 17543584·Lancet Oncol·2007
4-observational
Catalytic destruction of 1,2-dichlorobenzene on V2O5-WO3/Al2O3-TiO2 catalyst.
PMID 17239926·Chemosphere·2007
4-observational
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
PMID 16950362·Lancet·2006
1-meta
Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials.
PMID 16943534·J Clin Oncol·2006
8-other
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
PMID 16595780·J Natl Cancer Inst·2006
3-trial
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
PMID 16161069·Head Neck·2005
4-observational
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
PMID 15128893·N Engl J Med·2004
3-trial
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
PMID 14967419·Int J Radiat Oncol Biol Phys·2004
3-trial
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
PMID 14645636·N Engl J Med·2003
3-trial
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.
PMID 14581419·J Clin Oncol·2003
3-trial
Compliance with breast-conservation standards for patients with early-stage breast carcinoma.
PMID 12569588·Cancer·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 CAMEO LN
GREENSBURG, PA 15601 - Phone
- (724) 238-6668
Quick Facts
- NPI
- 1952744054
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile